Futura Capital Surpluse from 2010 to 2024

FUM Stock   33.67  0.75  2.28%   
Futura Medical's Capital Surpluse is increasing over the years with slightly volatile fluctuation. Capital Surpluse is expected to dwindle to about 53.2 M. During the period from 2010 to 2024 Futura Medical Capital Surpluse annual values regression line had geometric mean of  48,312,378 and mean square error of 6.9 T. View All Fundamentals
 
Capital Surpluse  
First Reported
2010-12-31
Previous Quarter
60.7 M
Current Value
53.2 M
Quarterly Volatility
5.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Futura Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Futura Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 136.8 K, Interest Expense of 0.0 or Other Operating Expenses of 10.6 M, as well as many indicators such as . Futura financial statements analysis is a perfect complement when working with Futura Medical Valuation or Volatility modules.
  
This module can also supplement various Futura Medical Technical models . Check out the analysis of Futura Medical Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Futura Stock

Futura Medical financial ratios help investors to determine whether Futura Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Futura with respect to the benefits of owning Futura Medical security.